Literature DB >> 7864101

Differential effects of interleukin-1 receptor antagonist in cytokine- and endotoxin-treated rats.

P R Ling1, N W Istfan, E Colon, B R Bistrian.   

Abstract

Previous studies have demonstrated that the administration of the cytokines, interleukin-1 (IL-1) and tumor necrosis factor (TNF)(20 micrograms/kg) to rats in a fasting state can produce many and perhaps most of the metabolic alterations found in patients with sepsis and injury. The purposes of the present study were 1) to define the metabolic effects of IL-1 and TNF during a fed state provided by continuous intravenous feeding for 20 h and 2) to characterize the unique effects of IL-1 among the overall response to cytokines by using IL-1 receptor antagonist (IL-1RA; 5 mg/kg). The effects were also explored during the endotoxemic condition induced by infusion of 200 micrograms/kg of endotoxin into rats. The results showed that during feeding IL-1 is responsible for the increase in glucose flux and plasma insulin, the development of insulin resistance, and plasma zinc depression during condition mimicking sepsis and injury, similar to effects observed in the fasting state. The changes in energy expenditure have a more complex mechanism. The results also suggested that certain host responses to cytokines or endotoxin, particularly related to protein metabolism, differed between the fed and fasting states. These data may have a special clinical relevance for the insulin-resistant state that develops during severe infection, since using IL-1RA in conjunction with nutritional therapy may offer additional advantages in the treatment of these severe metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864101     DOI: 10.1152/ajpendo.1995.268.2.E255

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Interleukin-1 signaling contributes to acute islet compensation.

Authors:  Catherine Hajmrle; Nancy Smith; Aliya F Spigelman; Xiaoqing Dai; Laura Senior; Austin Bautista; Mourad Ferdaoussi; Patrick E MacDonald
Journal:  JCI Insight       Date:  2016-04-07

2.  The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus.

Authors:  Fernando Llambés; Francisco-Javier Silvestre; Antonio Hernández-Mijares; Rami Guiha; Raúl Caffesse
Journal:  Clin Oral Investig       Date:  2008-04-30       Impact factor: 3.573

3.  Effect of non-surgical periodontal treatment on HbA1c levels in non-diabetic patients with chronic periodontitis in an Iranian population.

Authors:  Fereshteh Naseralavi; Masumeh Nikkhah; Nastaran Etemadi; Ashkan Salari
Journal:  J Adv Periodontol Implant Dent       Date:  2019-12-18

4.  Efficacy of nonsurgical periodontal therapy on glycaemic control in type II diabetic patients: a randomized controlled clinical trial.

Authors:  Ravishankar Lingesha Telgi; Vaibhav Tandon; Pradeep Shankar Tangade; Amit Tirth; Sumit Kumar; Vipul Yadav
Journal:  J Periodontal Implant Sci       Date:  2013-08-31       Impact factor: 2.614

Review 5.  Periodontal disease and diabetes mellitus.

Authors:  Carlos Antonio Negrato; Olinda Tarzia; Lois Jovanovič; Luiz Eduardo Montenegro Chinellato
Journal:  J Appl Oral Sci       Date:  2013 Jan-Feb       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.